Pleural mesothelioma side populations have a precursor phenotype

Carcinogenesis

Volumn 32, Issue 9, 2011, Pages 1324-1332

  Frei, Claudia ^a   Opitz, Isabelle ^a   Soltermann, Alex ^a   Fischer, Bruno ^a   Moura, Ubiratan ^a   Rehrauer, Hubert ^b   Weder, Walter ^a   Stahel, Rolf ^a   Felley Bosco, Emanuela ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b FUNCTIONAL GENOMICS CENTER ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER RECURRENCE; CANCER RESISTANCE; CELL STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIUM; PHENOTYPE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SIDE POPULATION CELL;

EID: 80052411937     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr127     Document Type: Article

References (58)

1. Peto, J. et al. (1999) The European mesothelioma epidemic. Br. J. Cancer, 79, 666-672.
2. Stahel, R.A. et al. (2009) Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach? Curr. Opin. Oncol., 21, 124-130.
3. vanMeerbeeck, J.P. et al. (2011) Malignant pleural mesothelioma: the standard of care and challenges for future management. Crit. Rev. Oncol. Hematol. 78, 92-111.
4. Beachy, P.A. et al. (2004) Tissue repair and stem cell renewal in carcinogenesis. Nature, 432, 324-331.
5. Mossman, B. et al. (1983) Asbestos: mechanisms of toxicity and carcinogenicity in the respiratory tract. Annu. Rev. Pharmacol. Toxicol., 23, 595-615.
6. Donaldson, K. et al. (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part. Fibre Toxicol., 7, 5.
7. Reya, T. et al. (2001) Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
8. Lapidot, T. et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367, 645-648.
9. Bonnet, D. et al. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med., 3, 730-737.
10. Al-Hajj, M. et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA, 100, 3983-3988.
11. Cho, R.W. et al. (2008) Recent advances in cancer stem cells. Curr. Opin. Genet. Dev., 18, 48-53.
12. Goodell, M.A. et al. (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med., 183, 1797-1806.
13. Zhou, S. et al. (2001) The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat. Med., 7, 1028-1034.
14. Scharenberg, C.W. et al. (2002) The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood, 99, 507-512.
15. Kai, K. et al. (2010) Characterization of side population cells in human malignant mesothelioma cell lines. Lung Cancer, 70, 146-151.
16. Thurneysen, C. et al. (2009) Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer, 64, 140-147.
17. Sidi, R. et al. (2011) Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: an exploratory analysis. Eur. J. Cancer, 47, 326-332.
18. Connell, N.D. et al. (1983) Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell, 34, 245-253.
19. Schmitter, D. et al. (1992) Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: interleukin-6 production as a common feature. Int. J. Cancer, 51, 296-301.
20. Ke, Y. et al. (1989) Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am. J. Pathol., 134, 979-991.
21. Belyanskaya, L.L. et al. (2007) Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin. Mol. Cancer, 6, 66.
22. Goodell, M.A. (2002) Multipotential stem cells and ′side population′ cells. Cytotherapy, 4, 507-508.
23. Telford, W.G. et al. (2007) Side population analysis using a violet-excited cell-permeable DNA binding dye. Stem Cells, 25, 1029-1036.
24. Morgan, J. et al. (2010) Substrate affinity of photosensitizers derived from Chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to Photodynamic Therapy. Mol. Pharm, in press.
25. Watson, J.V. et al. (1985) Flow cytometric fluorescence emission spectrum analysis of Hoechst-33342-stained DNA in chicken thymocytes. Cytometry, 6, 310-315.
26. Ozvegy-Laczka, C. et al. (2005) Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface. J. Biol. Chem., 280, 4219-4227.
27. O'Brien, C.A. et al. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110.
28. Patrawala, L. et al. (2005) Side population is enriched in tumorigenic, stemlike cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res., 65, 6207-6219.
29. Montanaro, F. et al. (2004) Demystifying SP cell purification: viability, yield, and phenotype are defined by isolation parameters. Exp. Cell Res., 298, 144-154.
30. Kondo, T. et al. (2004) Persistence of a small subpopulation of cancer stemlike cells in the C6 glioma cell line. Proc. Natl Acad. Sci. USA, 101, 781-786.
31. Chang, K. et al. (1996) Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc. Natl Acad. Sci. USA, 93, 136-140.
32. Doglioni, C. et al. (1996) Calretinin: a novel immunocytochemical marker for mesothelioma. Am. J. Surg. Pathol., 20, 1037-1046.
33. Chu, A.Y. et al. (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod. Pathol., 18, 105-110.
34. Travis, W. et al. (1999) WHO international histological classification of tumours: histological typing of lung and pleural tumours. 3rd edn. Springer-Verlag, Berlin, Germany.
35. Jackson, S.P. et al. (2009) The DNA-damage response in human biology and disease. Nature, 461, 1071-1078.
36. Falleni, M. et al. (2005) Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. Lung Cancer, 48, 211-216.
37. Belyanskaya, L.L. et al. (2005) Cisplatin activates Akt in small cell lung cancer cells and attenuates apoptosis by survivin upregulation. Int. J. Cancer, 117, 755-763.
38. Mutsaers, S.E. (2002) Mesothelial cells: their structure, function and role in serosal repair. Respirology, 7, 171-191.
39. Wu, C. et al. (2008) Side population cells in human cancers. Cancer Lett., 268, 1-9.
40. Hirschmann-Jax, C. et al. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl Acad. Sci. USA, 101, 14228-14233.
41. Rabindran, S.K. et al. (2000) Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res., 60, 47-50.
42. Robinson, C. et al. (2011) MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma. Eur. J. Cancer, 47, 151-161.
43. Lansley, S.M. et al. (2010) Mesothelial cell differention into osteoblast- and adipocyte-like cells. J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2010. 01212.x.
44. Mahtab, E.A. et al. (2008) Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: correlation with abnormal epicardial development. Dev. Dyn., 237, 847-857.
45. Hastie, N.D. (1994) The genetics of Wilms' tumor-a case of disrupted development. Annu. Rev. Genet., 28, 523-558.
46. Amin, K.M. et al. (1995) Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol., 146, 344-356.
47. Kumar-Singh, S. et al. (1997) WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis. J. Pathol., 181, 67-74.
48. Hinterberger, M. et al. (2007) D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod. Pathol., 20, 248-255.
49. Padgett, D.M. et al. (2008) Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am. J. Surg. Pathol., 32, 123-127.
50. Takeshima, Y. et al. (2009) Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma. Histopathology, 54, 667-676.
51. Stahel, R.A. et al. (2009) Malignant pleural mesothelioma. Future Oncol., 5, 391-402.
52. Chen, C.Z. et al. (2002) Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc. Natl Acad. Sci. USA, 99, 15468-15473.
53. Bernabeu, C. et al. (2009) The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim. Biophys. Acta, 1792, 954-973.
54. Grichnik, J.M. et al. (2006) Melanoma, a tumor based on a mutant stem cell? J. Invest. Dermatol., 126, 142-153.
55. Bortolomai, I. et al. (2010) Tumor initiating cells: development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension. Cell Cycle, 9, 1194-1206.
56. Singh, A. et al. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-4751.
57. Tabata, C. et al. (2009) All-trans-retinoic acid inhibits tumour growth of malignant pleural mesothelioma in mice. Eur. Respir. J., 34, 1159-1167.
58. Bollig, F. et al. (2009) A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros. Development, 136, 2883-2892.